TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
IMTX

Immatics NV

Healthcare · Biotechnology

8.60$ +0.7% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow IMTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
548.6% 384.7% -273.9% -235.3% 57.9% 33.8% -101.4% -351.5%
57.7% 20.9% 14.2% 15.1% 4.0% 13.4% 7.8% 24.7%
39.2% 4.6% 73.4% 76.0% 13.1% 38.3% 11.3% 31.1%
20.9% 9.8% -20.0% 109.3% 10.6% – – –
1,304.1% 525.1% -80.9% -91.2% 21.6% 151.2% -105.2% -87.5%
13.4% 12.1% 24.1% 16.3% 3.6% 57.3% 10.6% 13.1%
-358.5% -27.4% -51.0% 21.6% -121.4% -58.1% -97.8% 407.5%
3,970.9% – – – – – – –
-49.4% -10.1% -6.7% -7.8% -1.6% -7.1% -1.3% -6.1%
627.3% -10.1% 665.2% -7.5% 71.6% 156.5% 205.1% 193.7%
821.0% 346.8% 333.3% -214.4% 9.0% 129.5% 11.7% 284.1%
535.2% 372.6% -298.0% -251.5% 54.3% -23.6% -112.0% -364.6%

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?